The prognostic effect of coronary artery calcification in locally advanced non-small cell lung cancer: An independent prognostic factor after adjustment for clinical and dosimetric variables
{"title":"The prognostic effect of coronary artery calcification in locally advanced non-small cell lung cancer: An independent prognostic factor after adjustment for clinical and dosimetric variables","authors":"Yui Watanabe , Yutaro Koide , Takahiro Aoyama , Shingo Hashimoto , Hiroyuki Tachibana , Takeshi Kodaira","doi":"10.1016/j.rcro.2025.100352","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Although several studies have reported the prognostic significance of coronary artery calcification (CAC) for overall survival (OS) in patients with locally advanced non-small cell lung cancer (LA-NSCLC), the number of cohorts focusing on patients treated with definitive radiotherapy is limited, and the role of CAC as an independent predictor of OS remains underexplored. This study aimed to evaluate the independent prognostic value of CAC for OS in patients with LA-NSCLC undergoing definitive radiotherapy by incorporating this variable into a prognostic model.</div></div><div><h3>Material and methods</h3><div>This study enrolled 140 patients with LA-NSCLC (stage III, 92.1 %) who underwent definitive radiotherapy between 2015 and 2021. The primary endpoint was OS, assessed over a fixed three-year follow-up period. We analyzed the relationships between patient characteristics, CAC, and radiation doses to critical organs. Prognostic models using a simple scoring for predicting OS were developed, and their predictive performance was evaluated.</div></div><div><h3>Results</h3><div>Univariate Cox regression revealed that CAC in multiple vessels (HR, 2.6 [1.5–4.8]; p = 0.001), elevated mean heart dose (MHD; hazard ratio [HR], 4.0 [2.2–7.3]; p < 0.001), and higher total Lung V20 (HR, 2.8 [1.5–5.5]; p = 0.002) were significantly associated with decreased OS. These factors remained independently significant in multivariate analysis: the number of vessels with CAC (p = 0.023), MHD (p = 0.046), and total Lung V20 (p = 0.027). Kaplan-Meier survival analysis demonstrated that simple scoring models based on total Lung V20, MHD and CAC provided enhanced risk stratification for OS (p < 0.001).</div></div><div><h3>Conclusions</h3><div>We identified CAC as an independent prognostic factor for OS in patients with LA-NSCLC undergoing definitive radiotherapy. Furthermore, a simple scoring model incorporating CAC, MHD, and total Lung V20 provided improved risk stratification for OS.</div></div>","PeriodicalId":101248,"journal":{"name":"The Royal College of Radiologists Open","volume":"3 ","pages":"Article 100352"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Royal College of Radiologists Open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2773066225001184","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Although several studies have reported the prognostic significance of coronary artery calcification (CAC) for overall survival (OS) in patients with locally advanced non-small cell lung cancer (LA-NSCLC), the number of cohorts focusing on patients treated with definitive radiotherapy is limited, and the role of CAC as an independent predictor of OS remains underexplored. This study aimed to evaluate the independent prognostic value of CAC for OS in patients with LA-NSCLC undergoing definitive radiotherapy by incorporating this variable into a prognostic model.
Material and methods
This study enrolled 140 patients with LA-NSCLC (stage III, 92.1 %) who underwent definitive radiotherapy between 2015 and 2021. The primary endpoint was OS, assessed over a fixed three-year follow-up period. We analyzed the relationships between patient characteristics, CAC, and radiation doses to critical organs. Prognostic models using a simple scoring for predicting OS were developed, and their predictive performance was evaluated.
Results
Univariate Cox regression revealed that CAC in multiple vessels (HR, 2.6 [1.5–4.8]; p = 0.001), elevated mean heart dose (MHD; hazard ratio [HR], 4.0 [2.2–7.3]; p < 0.001), and higher total Lung V20 (HR, 2.8 [1.5–5.5]; p = 0.002) were significantly associated with decreased OS. These factors remained independently significant in multivariate analysis: the number of vessels with CAC (p = 0.023), MHD (p = 0.046), and total Lung V20 (p = 0.027). Kaplan-Meier survival analysis demonstrated that simple scoring models based on total Lung V20, MHD and CAC provided enhanced risk stratification for OS (p < 0.001).
Conclusions
We identified CAC as an independent prognostic factor for OS in patients with LA-NSCLC undergoing definitive radiotherapy. Furthermore, a simple scoring model incorporating CAC, MHD, and total Lung V20 provided improved risk stratification for OS.